Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21575Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tsimihodimos, V. | en |
| dc.contributor.author | Kakafika, A. | en |
| dc.contributor.author | Elisaf, M. S. | en |
| dc.date.accessioned | 2015-11-24T19:15:52Z | - |
| dc.date.available | 2015-11-24T19:15:52Z | - |
| dc.identifier.issn | 0931-0509 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21575 | - |
| dc.rights | Default Licence | - |
| dc.subject | Clofibric Acid/*adverse effects/analogs & derivatives | en |
| dc.subject | Creatinine/*blood | en |
| dc.subject | Fenofibrate/*adverse effects | en |
| dc.subject | Fibric Acids | en |
| dc.subject | Gemfibrozil/*adverse effects | en |
| dc.subject | Humans | en |
| dc.subject | Hypolipidemic Agents/*adverse effects | en |
| dc.subject | Kidney Diseases/complications/physiopathology | en |
| dc.subject | Urea/blood | en |
| dc.title | Fibrate treatment can increase serum creatinine levels | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11390746 | - |
| heal.identifier.secondary | http://ndt.oxfordjournals.org/content/16/6/1301.1.full.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2001 | - |
| heal.journalName | Nephrol Dial Transplant | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Tsimihodimos-2001-Fibrate treatment ca.pdf | 41.37 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
